| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 21:48:36 UTC |
|---|
| Update Date | 2022-11-23 22:29:21 UTC |
|---|
| HMDB ID | HMDB0259292 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Troglitazone |
|---|
| Description | Troglitazone, also known as rezulin, belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position. Troglitazone is a drug which is used for the treatment of type ii diabetes mellitus. it is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise. Based on a literature review very few articles have been published on Troglitazone. This compound has been identified in human blood as reported by (PMID: 31557052 ). Troglitazone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Troglitazone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28) |
|---|
| Synonyms | | Value | Source |
|---|
| Rezulin | ChEBI | | Romglizone | ChEBI | | Troglitazona | ChEBI | | Troglitazonum | ChEBI | | Prelay | MeSH | | Warner-lambert brand OF troglitazone | MeSH | | Parke davis brand OF troglitazone | MeSH |
|
|---|
| Chemical Formula | C24H27NO5S |
|---|
| Average Molecular Weight | 441.54 |
|---|
| Monoisotopic Molecular Weight | 441.160993669 |
|---|
| IUPAC Name | 5-({4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione |
|---|
| Traditional Name | troglitazone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)O2)C(C)=C1O |
|---|
| InChI Identifier | InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28) |
|---|
| InChI Key | GXPHKUHSUJUWKP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1-benzopyrans. These are organic aromatic compounds that 1-benzopyran, a bicyclic compound made up of a benzene ring fused to a pyran, so that the oxygen atom is at the 1-position. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzopyrans |
|---|
| Sub Class | 1-benzopyrans |
|---|
| Direct Parent | 1-benzopyrans |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1-benzopyran
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Thiazolidinedione
- Monocyclic benzene moiety
- Benzenoid
- Dicarboximide
- Thiazolidine
- Carbonic acid derivative
- Thiocarbamic acid derivative
- Carboxylic acid derivative
- Ether
- Oxacycle
- Azacycle
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxygen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.45 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 19.1486 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.08 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2703.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 427.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 243.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 215.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 227.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1015.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1084.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 82.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1687.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 676.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2027.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 577.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 506.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 297.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 257.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| troglitazone,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C | 3787.1 | Semi standard non polar | 33892256 | | troglitazone,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C | 3580.1 | Standard non polar | 33892256 | | troglitazone,2TMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C | 4173.1 | Standard polar | 33892256 | | troglitazone,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C(C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C(C)(C)C | 4226.5 | Semi standard non polar | 33892256 | | troglitazone,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C(C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C(C)(C)C | 3959.0 | Standard non polar | 33892256 | | troglitazone,2TBDMS,isomer #1 | CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N([Si](C)(C)C(C)(C)C)C4=O)C=C3)O2)C(C)=C1O[Si](C)(C)C(C)(C)C | 4270.1 | Standard polar | 33892256 |
|
|---|